Cardiovascular Diseases: Cholesterol – What Impact for Europe?

Promoted content

Chronic diseases such as cardiovascular diseases are responsible for 86% of all deaths in Europe, siphoning off 70% to 80% of healthcare budgets – an estimated €700 billion per year. During the 2014 EU Summit on Chronic Diseases, the European Commission identified key actions to tackle those. The initiative was taken in response to a call by the United Nations to reduce Non Communicable Diseases by 25% by 2025.

So-called “bad” cholesterol increases the risks of heart diseases and stroke. According to the WHO, globally, a third of ischaemic heart disease is attributable to high cholesterol.

  • Is the current political leadership meeting the challenge of chronic diseases? Are EU initiatives in line with the UN target?
  • How to enhance prevention and act on major risk factors? What about vulnerable target groups?
  • Is education still a key element in the fight against bad cholesterol in the EU? Are consumers sufficiently informed?
  • How to promote patient empowerment in order to encourage them to get screened and diagnosed?

A EURACTIV Stakeholder Conference with the support of Sanofi / Regeneron.


Subscribe to our newsletters